These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17502127)

  • 1. The role of endothelial dysfunction in the pathogenesis of impaired diabetic wound healing: a novel therapeutic target?
    Laing T; Hanson R; Chan F; Bouchier-Hayes D
    Med Hypotheses; 2007; 69(5):1029-31. PubMed ID: 17502127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects.
    Krishnan ST; Quattrini C; Jeziorska M; Malik RA; Rayman G
    Diabetes Care; 2007 Dec; 30(12):3058-62. PubMed ID: 17898089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis.
    Candido R; Zanetti M
    Ital Heart J; 2005 Sep; 6(9):703-20. PubMed ID: 16212072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional drugs for endothelial dysfunction in diabetes and glaucoma.
    Wood PL
    IDrugs; 2003 Apr; 6(4):360-7. PubMed ID: 12789607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycoxidation products and impaired diabetic wound healing.
    Peppa M; Stavroulakis P; Raptis SA
    Wound Repair Regen; 2009; 17(4):461-72. PubMed ID: 19614910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targets.
    Madonna R; De Caterina R
    Vascul Pharmacol; 2011; 54(3-6):75-9. PubMed ID: 21453785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Sorrentino SA; Bahlmann FH; Besler C; Müller M; Schulz S; Kirchhoff N; Doerries C; Horváth T; Limbourg A; Limbourg F; Fliser D; Haller H; Drexler H; Landmesser U
    Circulation; 2007 Jul; 116(2):163-73. PubMed ID: 17592079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endothelial function on the foot. Microcirculation and wound healing in patients with diabetes.
    Pham HT; Economides PA; Veves A
    Clin Podiatr Med Surg; 1998 Jan; 15(1):85-93. PubMed ID: 9463769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular changes in the diabetic foot.
    Schramm JC; Dinh T; Veves A
    Int J Low Extrem Wounds; 2006 Sep; 5(3):149-59. PubMed ID: 16928671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
    Dandona P; Ghanim H; Chaudhuri A; Mohanty P
    J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-inflammatory agent Propolis improves wound healing in a rodent model of experimental diabetes.
    McLennan SV; Bonner J; Milne S; Lo L; Charlton A; Kurup S; Jia J; Yue DK; Twigg SM
    Wound Repair Regen; 2008; 16(5):706-13. PubMed ID: 19128266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.
    Farhangkhoee H; Khan ZA; Kaur H; Xin X; Chen S; Chakrabarti S
    Pharmacol Ther; 2006 Aug; 111(2):384-99. PubMed ID: 16343639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction in type 2 diabetes: effect of antioxidants.
    Sena CM; Nunes E; Louro T; Proença T; Seiça RM
    Rev Port Cardiol; 2007 Jun; 26(6):609-19. PubMed ID: 17849945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine 1-phosphate accelerates wound healing in diabetic mice.
    Kawanabe T; Kawakami T; Yatomi Y; Shimada S; Soma Y
    J Dermatol Sci; 2007 Oct; 48(1):53-60. PubMed ID: 17643267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diabetic foot: pathogenesis and clinical evaluation.
    Schaper NC; Nabuurs-Franssen MH
    Semin Vasc Med; 2002 May; 2(2):221-8. PubMed ID: 16222613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of angiopathy in diabetes.
    Skrha J
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S324-9. PubMed ID: 14704862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A potential mechanism for impaired wound healing--cutaneous environmental disorders in diabetes mellitus].
    Lu SL; Xie T; Niu YW
    Zhonghua Shao Shang Za Zhi; 2008 Feb; 24(1):3-5. PubMed ID: 18512549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. db/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model.
    Michaels J; Churgin SS; Blechman KM; Greives MR; Aarabi S; Galiano RD; Gurtner GC
    Wound Repair Regen; 2007; 15(5):665-70. PubMed ID: 17971012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products and diabetic foot disease.
    Huijberts MS; Schaper NC; Schalkwijk CG
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S19-24. PubMed ID: 18442180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes.
    Zimmerman MA; Flores SC
    J Surg Res; 2009 Jul; 155(1):173-8. PubMed ID: 18805553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.